Cargando…

Biological and prognostic impact of APOBEC-induced mutations in the spectrum of plasma cell dyscrasias and multiple myeloma cell lines

Detalles Bibliográficos
Autores principales:	Maura, F, Petljak, M, Lionetti, M, Cifola, I, Liang, W, Pinatel, E, Alexandrov, L B, Fullam, A, Martincorena, I, Dawson, K J, Angelopoulos, N, Samur, M K, Szalat, R, Zamora, J, Tarpey, P, Davies, H, Corradini, P, Anderson, K C, Minvielle, S, Neri, A, Avet-Loiseau, H, Keats, J, Campbell, P J, Munshi, N C, Bolli, N
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2018
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5886048/ https://www.ncbi.nlm.nih.gov/pubmed/29209044 http://dx.doi.org/10.1038/leu.2017.345

Ejemplares similares

Genomic patterns of progression in smoldering multiple myeloma
por: Bolli, Niccolò, et al.
Publicado: (2018)

A compendium of DIS3 mutations and associated transcriptional signatures in plasma cell dyscrasias
por: Lionetti, Marta, et al.
Publicado: (2015)

Genomic landscape and chronological reconstruction of driver events in multiple myeloma
por: Maura, Francesco, et al.
Publicado: (2019)

Expressed fusion gene landscape and its impact in multiple myeloma
por: Cleynen, A., et al.
Publicado: (2017)

The shaping and functional consequences of the dosage effect landscape in multiple myeloma
por: Samur, Mehmet K, et al.
Publicado: (2013)

Long Intergenic Non-Coding RNAs have an Independent Impact on Survival in Multiple Myeloma
por: Samur, Mehmet Kemal, et al.
Publicado: (2018)

Genome-Wide Somatic Alterations in Multiple Myeloma Reveal a Superior Outcome Group
por: Samur, Mehmet Kemal, et al.
Publicado: (2020)

A DNA target-enrichment approach to detect mutations, copy number changes and immunoglobulin translocations in multiple myeloma
por: Bolli, N, et al.
Publicado: (2016)

Association of a germline copy number polymorphism of APOBEC3A and APOBEC3B with burden of putative APOBEC-dependent mutations in breast cancer
por: Nik-Zainal, Serena, et al.
Publicado: (2014)

In-depth analysis of alternative splicing landscape in multiple myeloma and potential role of dysregulated splicing factors
por: Aktas Samur, Anil, et al.
Publicado: (2022)

Nucleotide excision repair is a potential therapeutic target in multiple myeloma
por: Szalat, R, et al.
Publicado: (2018)

Opium Dyscrasia
por: Moore,
Publicado: (1886)

Pus Dyscrasia
por: Barrett, W. C.
Publicado: (1881)

Monoallelic deletion of BCMA is a frequent feature in multiple myeloma
por: Samur, Mehmet Kemal, et al.
Publicado: (2023)

Deciphering the chronology of copy number alterations in Multiple Myeloma
por: Aktas Samur, Anil, et al.
Publicado: (2019)

Non-overlapping Control of Transcriptome by Promoter- and Super-Enhancer-Associated Dependencies in Multiple Myeloma
por: Fulciniti, Mariateresa, et al.
Publicado: (2018)

The dChip survival analysis module for microarray data
por: Amin, Samir B, et al.
Publicado: (2011)

Crusted Scabies in Systemic Sclerosis with Plasma Cell Dyscrasia
por: Nikam, Balkrishna P., et al.
Publicado: (2018)

Post-Arsphenamine Blood Dyscrasias
por: Rajam, R. V., et al.
Publicado: (1938)

The Non-Coding RNA Landscape of Plasma Cell Dyscrasias
por: Morelli, Eugenio, et al.
Publicado: (2020)

Mechanisms of APOBEC3 mutagenesis in human cancer cells
por: Petljak, Mia, et al.
Publicado: (2022)

Dysregulated APOBEC3G causes DNA damage and promotes genomic instability in multiple myeloma
por: Talluri, Srikanth, et al.
Publicado: (2021)

Quantitation of Monoclonal Plasma Cells in Bone Marrow Biopsies in Plasma Cell Dyscrasia
por: Markey, G. M., et al.
Publicado: (2003)

Telomerase activity in plasma cell dyscrasias
por: Xu, D, et al.
Publicado: (2001)

Basic Aural Dyscrasia and Vascular Deafness
Publicado: (1887)

Basic Aural Dyscrasia and Vascular Deafness
Publicado: (1886)

Ocular complications of plasma cell dyscrasias
por: Singh, Rohan Bir, et al.
Publicado: (2023)

Classify Hyperdiploidy Status of Multiple Myeloma Patients Using Gene Expression Profiles
por: Li, Yingxiang, et al.
Publicado: (2013)

The location of the t(4;14) translocation breakpoint within the NSD2 gene identifies a subset of patients with high-risk NDMM
por: Stong, Nicholas, et al.
Publicado: (2023)

The CCND1 c.870G risk allele is enriched in individuals of African ancestry with plasma cell dyscrasias
por: Baughn, Linda B., et al.
Publicado: (2020)

Mapping clustered mutations in cancer reveals APOBEC3 mutagenesis of ecDNA
por: Bergstrom, Erik N., et al.
Publicado: (2022)

A case of plasma cell dyscrasia presenting as nonscarring alopecia
por: Nia, Benjamin, et al.
Publicado: (2021)

APOBECs and Herpesviruses
por: Cheng, Adam Z., et al.
Publicado: (2021)

Structural basis for targeted DNA cytosine deamination and mutagenesis by APOBEC3A and APOBEC3B
por: Shi, K., et al.
Publicado: (2016)

Mutational landscape reflects the biological continuum of plasma cell dyscrasias
por: Rossi, A, et al.
Publicado: (2017)

The Distribution and Nature of Sprue, with Notes on the Pathology of Intestinal Dyscrasias
por: Brown, W. Carnegie
Publicado: (1907)

Pulmonary Vascular Disease Due to Plasma Cell Dyscrasia
por: Rajapreyar, Indranee, et al.
Publicado: (2020)

Imaging for Plasma Cell Dyscrasias: What, When, and How?
por: Guha, Amrita, et al.
Publicado: (2022)

Molecular spectrum of TP53 mutations in plasma cell dyscrasias by next generation sequencing: an Italian cohort study and overview of the literature
por: Lionetti, Marta, et al.
Publicado: (2016)

Quantitative and qualitative assessment of plasma cell dyscrasias in dual-layer spectral CT
por: Brandelik, S. C., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_jk4t76p84r6nk4kadggrru5kcv